BackSarepta Therapeutics Overview
Sarepta Therapeutics, Inc.

Sarepta Therapeutics PEG Ratio

Sarepta Therapeutics (0L35.L) has a PEG ratio of 12.1, above the Healthcare sector average of 0.46.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

12.10

PEG Ratio

12.10

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

Sarepta Therapeutics (0L35.L) FAQ

As of the most recent data, 0L35.L shows a PEG ratio of 12.1. That is above the Healthcare sector average of 0.46. Scroll down for historical charts and peer comparison views.

The Healthcare sector average PEG ratio is about 0.46. Sarepta Therapeutics is at 12.1, which is higher that average. That is roughly 2509.2% above the sector mean. Use the comparison chart on this page to see how 0L35.L stacks up against individual peers as well.

Investors watch 0L35.L's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Sarepta Therapeutics's latest reading is 12.1. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this peg ratio page, Stockcircle has Sarepta Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 12.1) with ownership activity and broader fundamentals.

The Healthcare average PEG ratio is about 0.46, while 0L35.L is at 12.1. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.